Sardar Chemical Industries Ltd.PSX: SARC

Financial results for the quarter ended 31-03-2025

· Issued by Sardar Chemical Industries Ltd.


INTERIM CONDENSED BALANCE SHEET (UN-AUDITED)



AS AT MARCH 31, 2025

NOTE MAR 2025

60,000,000

60,000,000

30,000,000

30,000,000

236,066,141

214,162,165

8,825,219

6,412,339

31,886,790

34,785,S88

3,108,750

3,108,750

4,705,248

6,412,986

33,942,435

36,801,188

34,684,524

35,184,524

3,698,933

2,205,234

RUPEES

2024

RUPEES

EQUITY AND LIABIUTIES

Share capital and reserves

Authorised Capital:

100,000,000

100,000,000

rssuied bsubs baend P id u

Share capital - ordinary shares of Rs. 10/- each



Share premium - capital reserve

Accumulated profits - revenue reserve

Non-current liabilities

326,066,141

304,162,165

Lease liabilities

S

Long term loan

6

Deferred tax liabilities

13

43,820,759

44,306,677

Current liabilities

Current portion of long-term liabilities

7

Trade and other payables

8

Loan from directors

9

Unclaimed dividend

10

77,031,140

80,603,932

Contingencies and commitments

11

446,918,040

429,072,774

ASSETS

Non-current assets

Property, plant and equipment

12

Deferred tax asset

13

Long term deposits

14

86,318,744

90,Y64,677

Current assets

Advances, deposits, prepayments and other receivables

15

Stores, spares and loose tools

16

Stock-in-trade

17

Trade debts

18

Taxation- net

19

Cash and bank balances

20

360,599,296

338,308,097

(0)

446,918,040

429,072,774



81,526,464

86,191,447

4,792,280

4,573,230

2,963,305

1,834,816

890,222

820,773

122,355,776

120,561,011

191,926,243

186,166,984

16,900,961

15,831,349

2S,562,789

13,093,163

Chief Executive Chief Financial Officer

Director



SA •x CHEhficzz tsavsrzizs LIMITED

INTERIM CONDENSEDPROFIT AND LOSS ACCOUNT FOR THE THIRD QUARTER ENDED MARCH 31, 2025 (UN-AUDITED)

9 Months Ended t}uarter Ended

31 Maf.

31 Mar.

31 Mar.

31 Mar.

2025

2024

202S

2024

Rupees

Rupees

Rupees

Rupees

Sales

Cost of Sales

Gross Profit

OPERATING EXPENSES

395,862,738 376,788,025 139,872,599 110,144,387

(287,682,694) (254,933,787) (104,561,601) (76,143,992) 108,180,044 121,854,239 35,310,998 34,000,395

Administrative

(48,952,019)

(40,593,182)

(16,661,654)

(15,541,511)

Selling and distribution

(15,637,684)

(14,522,649)

(6,890,072)

(4,772,169)

(84,489,603)

(55,115,831)

(22,551,726)

(20,313,680)

Operating Profit/(Loss) For

3]690]441

66,738,407

12,759,271

13,d86,714

The period

Other Operating Income



2,914,402

533,089

Other Operating Expenses

(3,469,857)

Finance Cost

(6,9sa,os4j

(8,182,328)

(2,355,533)

(2,613,284)

Profit/ (Loss) before

38,248,849

58,000,624

10,403,738

11,606,519

taxation

Taxation

(11,120,873)

(16,929,133)

(3,033,302)

(3,679,842)

ProflV(loss)for the period

27,127,976

41,071,491

7,370,436

7,926,677

Earning/(loss) per share

4.52

6.85

1.23

1.a3



Chief Financial Officer





Chief Executive

Director

I ERI 'ON

E**NS

ATEMENT F**C ANGES'N

EQUITY (UN-

AUDITED) AS AT 31 MARCH 2025

Share Capital

Share Premium

Un-appropriated

p,ofiV

Rupees

Total

(Accumulated Loss)

Balance at

30" June 2023

60,000,000

30,000,000

161,832,737

251,832,737

Profit for

the period ended

31 Dec. 2023

-

33,144,815

33,144,815

Balance at

31 Dec. 2023

60,000,000

30,000,000

194,977,552

284.977,552

Profit for

the period ended

30 June 2024

19 184,613

19,184,613

Balance at

the period ended

30 June. 2024

60,000.000

30.000,000

214,162,165

304,162,165

Profit for

The period ended

31 Dec. 2024

-

19 757,540

19,757,540

Final dividend

paid

-

(5 224,000)

(5 224 000)

Balance at

31 Dec. 2024

60,000,000

30,000,000

228,695,705

318,695,705

Profit for

the period ended

31 Mar. 2025

-

7,370,436

7,370,436

Balance at

31 Mar. 2025

60,000,000

30,000,000

236,066,141

326,066,141



Chief Executive

Chief Financial Officer

Director



INTERIM CONDENSED STATEMENT OF CASH FLOW (UN-AUDITED)

AS AT MARCH 3f, 2025

cash €ow from opeatlng activiñes ProfiV(Loss) before taxation

Adjustment of non-Cash Items. Depreciation.

Financial Charges

Profit on sale of fixed assets

Profit before working capital changes

MARCH 31,2025

Rupees

38,248,849

7,529,883

6,966,064

t4,495,947

Effect of working capital changes

(Increase) /Decrease in store, spare and loose tools (69,449)

(80,690)

(Increase) /Decrease in stock in trade (1,794,765)

(12,625,203)

(Increase) decrease in trade debts (5,759,259)

(22,695,494)

(Increase) /Decrease in sales tax refundable

594,246

(Increase)/Decrease in advances, deposit and (1,128,489)

Prepayments

Increase/(Decrease) in creditors accrued and other 1,275,543

(14,200,837)

14,856,923

Liabilities

(Increase) /Decrease in Unclaimed divided

(2,037,103)

(7,476,419)

(36,782,404)

Financial charges paid

(6,966,064)

(8,182,328)

Workers profit participation fund paid

(4,134,296)

Tax paid

(12,190,486)

(13,538,709)

(23,290,846)

(21,721,037)

Net cash generated from operating activities Cash flow from Investing activities:

A

21,977,531

11,006,474

Fixed Capital expenditure

(157,900)

Long term deposits

Sale proceeds of fixed assets

(219,050)

559,600

Net Cash used In Investing activities B

(376,950)

559,600

Cash flow from financing activities

(Repayment)/ proceeds of lease obligation

(2,968,122)

(3,820,461)

(Repayment)/ proceeds of short-term finances (Repayment)/ proceeds of Long term loan

(500,000)

(10,815,476)

Divided paid

(3,730,301)

(94,112)

Net cash used in financing actlvldes

(9,130,955

(14,730,049)

Net Increase/ (Decrease) in cash and cash

12,469,626

(3,163,975)

Equivalents A4B+C

Caah and c8Bh Equivalents at beginning of the

t3,093,163

18,739,826

Period

Caah and cash Equivalents at end of the period

25,562,789

15,575,851

52,744,796

MARCH

31,2024

Rupees

58,000,624

3,326,963

8,182,328

11,509,291

69,509,915





(1,932,532)







Chief Executive

Chief Financial Officer

Director

Earlier from Sardar Chemical Industries

All Sardar Chemical Industries news releases